MRKR logo

Marker Therapeutics (MRKR) Depreciation And Amortization

MRKR Annual D&A

N/A

31 December 2023

All-time High

$3.16 M
MRKR annual depreciation & amortization is currently at an all-time high
Annual Total Expenses$14.58 M
MRKR annual total expenses is $14.58 million
Annual Operating Expenses$14.58 M
MRKR annual total operating expenses is $14.58 million
Annual Net Income-$8.24 M
MRKR annual net profit is -$8.24 million

MRKR Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRKR Quarterly D&A

N/A

30 September 2024

All-time High

$834.20 K
MRKR quarterly depreciation & amortization is currently at an all-time high
Quarterly Total Expenses$2.40 M
MRKR quarterly total expenses is $2.40 million
Quarterly Operating Expenses$2.40 M
MRKR quarterly total operating expenses is $2.40 million
Quarterly Net Income-$2.31 M
MRKR quarterly net profit is -$2.31 million

MRKR Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRKR TTM D&A

N/A

30 September 2024

All-time High

$3.24 M
MRKR TTM depreciation & amortization is currently at an all-time high
Annual Total Expenses$14.58 M
MRKR annual total expenses is $14.58 million
Annual Operating Expenses$14.58 M
MRKR annual total operating expenses is $14.58 million
TTM Net Income-$9.70 M
MRKR TTM net profit is -$9.70 million

MRKR TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRKR Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

MRKR Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

Marker Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
June 2022
-
-$834.20 K(-200.0%)
$1.63 M(-49.9%)
Mar 2022
-
$834.20 K(+1.7%)
$3.24 M(+2.5%)
Dec 2021
$3.16 M(+194.0%)
$820.20 K(+1.9%)
$3.16 M(+12.6%)
Sept 2021
-
$805.30 K(+2.9%)
$2.81 M(+17.4%)
June 2021
-
$782.80 K(+3.8%)
$2.39 M(+36.8%)
Mar 2021
-
$754.40 K(+62.1%)
$1.75 M(+62.5%)
Dec 2020
$1.08 M(+275.3%)
$465.40 K(+19.7%)
$1.08 M(+55.7%)
Sept 2020
-
$388.70 K(+179.6%)
$691.10 K(+82.3%)
June 2020
-
$139.00 K(+68.3%)
$379.20 K(+20.6%)
Mar 2020
-
$82.60 K(+2.2%)
$314.50 K(+9.7%)
Dec 2019
$286.60 K(>+9900.0%)
$80.80 K(+5.2%)
$286.60 K(+39.3%)
Sept 2019
-
$76.80 K(+3.4%)
$205.80 K(+59.5%)
June 2019
-
$74.30 K(+35.8%)
$129.00 K(+135.8%)
Mar 2019
-
$54.70 K(>+9900.0%)
$54.70 K(>+9900.0%)
Dec 2018
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sept 2018
-
$0.00(0.0%)
$0.00(0.0%)
June 2018
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00(0.0%)
$0.00(0.0%)
June 2013
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2012
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sept 2012
-
$0.00(0.0%)
$0.00(0.0%)
June 2012
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2012
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2011
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
June 2011
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2009
$3700.00(-50.7%)
$0.00(-100.0%)
$3800.00(-33.3%)
Sept 2009
-
$100.00(-94.4%)
$5700.00(-24.0%)
June 2009
-
$1800.00(-5.3%)
$7500.00(-1.3%)
Mar 2009
-
$1900.00(0.0%)
$7600.00(0.0%)
Dec 2008
$7500.00
$1900.00(0.0%)
$7600.00(0.0%)
Sept 2008
-
$1900.00(0.0%)
$7600.00(-8.4%)
June 2008
-
$1900.00(0.0%)
$8300.00(+12.2%)
DateAnnualQuarterlyTTM
Mar 2008
-
$1900.00(0.0%)
$7400.00(+23.3%)
Dec 2007
$6000.00(-6.3%)
$1900.00(-26.9%)
$6000.00(+39.5%)
Sept 2007
-
$2600.00(+160.0%)
$4300.00(+104.8%)
June 2007
-
$1000.00(+100.0%)
$2100.00(-47.5%)
Mar 2007
-
$500.00(+150.0%)
$4000.00(-37.5%)
Dec 2006
$6400.00(-91.0%)
$200.00(-50.0%)
$6400.00(-89.2%)
Sept 2006
-
$400.00(-86.2%)
$59.40 K(-0.5%)
June 2006
-
$2900.00(0.0%)
$59.70 K(-9.1%)
Mar 2006
-
$2900.00(-94.5%)
$65.70 K(-8.2%)
Dec 2005
$71.50 K(-294.8%)
$53.20 K(+7500.0%)
$71.60 K(-252.7%)
Sept 2005
-
$700.00(-92.1%)
-$46.90 K(+21.2%)
June 2005
-
$8900.00(+1.1%)
-$38.70 K(+2.1%)
Mar 2005
-
$8800.00(-113.5%)
-$37.90 K(+3.6%)
Dec 2004
-$36.70 K(-186.6%)
-$65.30 K(-833.7%)
-$36.60 K(-193.4%)
Sept 2004
-
$8900.00(-8.2%)
$39.20 K(-3.9%)
June 2004
-
$9700.00(-4.0%)
$40.80 K(-2.4%)
Mar 2004
-
$10.10 K(-3.8%)
$41.80 K(-1.4%)
Dec 2003
$42.40 K(+3.7%)
$10.50 K(0.0%)
$42.40 K(+0.5%)
Sept 2003
-
$10.50 K(-1.9%)
$42.20 K(-32.2%)
June 2003
-
$10.70 K(0.0%)
$62.20 K(+50.6%)
Mar 2003
-
$10.70 K(+3.9%)
$41.30 K(+1.2%)
Dec 2002
$40.90 K(+1139.4%)
$10.30 K(-66.2%)
$40.80 K(+429.9%)
Sept 2002
-
$30.50 K(-399.0%)
$7700.00(>+9900.0%)
June 2002
-
-$10.20 K(-200.0%)
$0.00(-100.0%)
Mar 2002
-
$10.20 K(-144.7%)
$5000.00(>+9900.0%)
Dec 2001
-
-$22.80 K(-200.0%)
$0.00(-100.0%)
Sept 2001
-
$22.80 K(-538.5%)
$10.60 K(-253.6%)
June 2001
-
-$5200.00(-200.0%)
-$6900.00(-291.7%)
Mar 2001
-
$5200.00(-142.6%)
$3600.00(+9.1%)
Dec 2000
$3300.00(-81.4%)
-$12.20 K(-330.2%)
$3300.00(-78.7%)
Sept 2000
-
$5300.00(0.0%)
$15.50 K(+52.0%)
June 2000
-
$5300.00(+8.2%)
$10.20 K(+108.2%)
Mar 2000
-
$4900.00
$4900.00
Dec 1999
$17.70 K
-
-

FAQ

  • What is the all time high annual D&A for Marker Therapeutics?
  • What is the all time high quarterly D&A for Marker Therapeutics?
  • What is the all time high TTM D&A for Marker Therapeutics?

What is the all time high annual D&A for Marker Therapeutics?

Marker Therapeutics all-time high annual depreciation & amortization is $3.16 M

What is the all time high quarterly D&A for Marker Therapeutics?

Marker Therapeutics all-time high quarterly depreciation & amortization is $834.20 K

What is the all time high TTM D&A for Marker Therapeutics?

Marker Therapeutics all-time high TTM depreciation & amortization is $3.24 M